BACKGROUND: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related
mortality worldwide. Viral hepatitis, alcoholism and non-alcoholic steatohepatitis are the …

Hepatocellular carcinoma is one of the most prevalent life-threatening human cancers with
etiological factors chronic viral hepatitis B and C infections. Tumor cell dispersion relies on …

Background: Lipocalin 2 has been implicated in colorectal tumorigenesis but its usefulness
as a diagnostic marker for the disease has previously never been determined. Methods: We …

Excess calorie intake and a sedentary lifestyle have made non-alcoholic fatty liver disease
(NAFLD) one of the fastest growing forms of liver disease of the modern world. It is …

We validated a single-stranded, DNA aptamer-based, diagnostic method capable of
detecting Lipocalin-2 (LCN2), a biomarker from clinically relevant hepatocellular carcinoma …

1. Abstract Lipocalin 2 (LCN2) is a 25 kDa secreted protein, initially purified from neutrophil
granules, and mainly expressed in immune cells, hepatocytes, renal cells, prostate, cells of …

Purpose Hepatocellular carcinoma (HCC) ranks fifth among the common cancers
worldwide. Hepatocarcinogenesis is a multiple-phases process, which involves changes in …

BACKGROUND: Endometrial cancer is one of the most common tumor of the woman genital
organs. OBJECTIVE: The goal of this study was to determine the lipocalin-2 levels in …

Hepatoblastoma (HB) is the most common pediatric liver malignant tumor. Previously, we
reported co-activation of β-catenin and Yes-associated protein-1 (YAP1) in 80% of HB …

We recently identified lipocalin2 (LCN2) as being upregulated in ovarian cancer cell lines.
The purpose of this study was to validate LCN2 upregulation in ovarian cancers and to …